News Breaks |
|
|
| October 26, 2012 |
| 10:00 EDT |  | ALKS, MDCO, BCEI, DKS, VAR, CBRL, ARIA, ARQL | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ARIAD (ARIA) initiated with a Buy at Citigroup... Alkermes (ALKS) initiated with a Buy at Citigroup... ArQule (ARQL) initiated with a Buy at Citigroup... Bonanza Creek Energy (BCEI) initiated with a Buy at SunTrust... Dick's Sporting (DKS) initiated with a Market Perform at BMO Capital... The Medicines Co. (MDCO) initiated with a Neutral at Citigroup... Varian Medical (VAR) initiated with a Buy at Brean Capital... Cracker Barrel (CBRL) initiated with a Buy at CL King. |
|
|
News For ARIA;ARQL;ALKS;MDCO;BCEI;DKS;VAR;CBRL From The Last 14 Days Check below for free stories on ARIA;ARQL;ALKS;MDCO;BCEI;DKS;VAR;CBRL the last two weeks. |
|
|
| May 24, 2013 |
| 10:04 EDT |  | ALKS | On The Fly: Analyst Downgrade Summary
 Subscribe for More Information |
|
| 09:26 EDT |  | DKS | Dick's Sporting price target raised to $60 from $55 at Imperial Capital
Subscribe for More Information |
|
| 08:36 EDT | | ALKS | Alkermes downgraded to Sell from Neutral at MKM Partners
Subscribe for More Information |
|
| May 23, 2013 |
| 07:48 EDT | | MDCO | The Medicines Co. decline unjustified, says RBC Capital
Subscribe for More Information |
|
| 07:08 EDT |  | ALKS | Alkermes changes fiscal year end, sees 9-months EPS 61c-75c
Alkermes has changed its fiscal year-end from March 31 to Dec. 31 and outlined financial expectations for the nine-month period ending Dec. 31, 2013. Alkermes expects total revenues to range from $395M-$425M, and non-GAAP net income to range from $85M-$105M or 61c-75c per share, for the nine months ending Dec. 31, 2013. Following the change in the company’s financial year-end, the company expects total pro forma revenues for the calendar year ending Dec. 31, 2013, to range from $558M-$588M and expects pro forma non-GAAP net income for the calendar year ending Dec. 31, 2013, to range from $141M-$161M. |
|
| 07:03 EDT |  | ALKS | Alkermes reports Q4 EPS 40c, may not compare to consensus 17c
Reports Q4 revenue $163.4M, consensus $128.01M. Revenues for the quarter included $30.0M of intellectual property license revenue unrelated to key development programs. |
|
| May 22, 2013 |
| 15:16 EDT | | MDCO | The Medicines Co. shares defended at ISI Group
Subscribe for More Information |
|
| 10:00 EDT | | DKS | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 08:01 EDT | | VAR | Varian Medical receives FDA clearance for Nexus DRF X-ray imaging system
Subscribe for More Information |
|
| 07:57 EDT | | DKS | Dick's Sporting price target raised to $61 from $57 at Susquehanna
Susquehanna raised its price target on Dick's Sporting following in-line Q1 results. The firm believes the company's September analyst day and Q2 results could be catalysts to move the shares higher. Shares are Positive rated. |
| |
| 07:36 EDT | | DKS | Dick's Sporting downgraded at BMO Capital
Subscribe for More Information |
|
| 06:15 EDT | | DKS | Dick's Sporting downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information |
|
| 05:55 EDT | | DKS | Dick's Sporting removed from Top Picks Live list at Citigroup
Subscribe for More Information |
|
| May 21, 2013 |
| 12:13 EDT | | MDCO | The Medicines Co. weakness a buying opportunity, says Credit Suisse
Subscribe for More Information |
|
| 11:49 EDT | | MDCO | The Medicines Co. weakness not related to fundamentals, says ISI Group
ISI Group said they spoke with The Medicines Company management and haven't found anything fundamental to explain today's weakness. The analyst also confirmed there was nothing new regarding the ongoing Angiomax litigation with the Judge's office and said today's AcelRx Ph. 3 data provided no new information. |
|
| 10:24 EDT |  | MDCO | The Medicines Co. spike lower, levels to watch
Subscribe for More Information |
|
| 10:21 EDT |  | MDCO | The Medicines Co. increases on wide intra-day price movement
The Medicines Co. June call option implied volatility is at 42, July is at 53, October is at 49; compared to its 26-week average of 39 according to Track Data, suggesting large price movement. |
|
| 10:16 EDT | | MDCO | The Medicines Co. falls 17.5% to $29.37
|
|
| 07:33 EDT | | DKS | Dick's Sporting sees FY13 CapEx $299M on gross basis
Subscribe for More Information |
|
| 07:33 EDT | | DKS | Dick's Sporting sees Q2 EPS 75c-77c, consensus 76c
Sees Q2 SSS up 2%-3%; Expects to open approximately seven new Dick's Sporting Goods stores in Q2. |
| |
|
|
|
|
